Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1974 Dec;6(6):869–870. doi: 10.1128/aac.6.6.869

In Vitro Susceptibility of Haemophilus influenzae to Trimethoprim-Sulfamethoxazole

Linda A Kirven 1, Clyde Thornsberry 1
PMCID: PMC444752  PMID: 4548834

Abstract

Thirty-four strains of Haemophilus influenzae (20 ampicillin sensitive and 14 ampicillin resistant), mostly type b isolates from cerebrospinal fluid or blood, were tested for susceptibility to a combination of trimethoprim-sulfamethoxazole (TMP-SMZ) in a ratio of 1 part TMP to 19 parts SMZ. All strains were very susceptible to the TMP-SMZ combination, with minimal inhibitory concentrations ranging from 0.007–0.14 to 0.06–1.18 μg of TMP-SMZ per ml. There was little difference in the susceptibility of the ampicillin-sensitive and ampicillin-resistant strains to TMP-SMZ.

Full text

PDF
869

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bach M. C., Finland M., Gold O., Wilcox C. Susceptibility of recently isolated pathogenic bacteria to trimethoprim and sulfamethoxazole separately and combined. J Infect Dis. 1973 Nov;128(Suppl):508–p. doi: 10.1093/infdis/128.supplement_3.s508. [DOI] [PubMed] [Google Scholar]
  2. Bushby S. R. Trimethoprim-sulfamethoxazole: in vitro microbiological aspects. J Infect Dis. 1973 Nov;128(Suppl):442–p. doi: 10.1093/infdis/128.supplement_3.s442. [DOI] [PubMed] [Google Scholar]
  3. Finland M., Kass E. H. Trimethoprim-sulfamethoxazole. Summary and comments on the conference. J Infect Dis. 1973 Nov;128(Suppl):792–816. doi: 10.1093/infdis/128.supplement_3.s792. [DOI] [PubMed] [Google Scholar]
  4. Garrod L. P. The possible scope of trimethoprim-sulphonamide treatment. Postgrad Med J. 1969 Nov;45(Suppl):52–55. [PubMed] [Google Scholar]
  5. Khan W., Ross S., Rodriguez W., Controni G., Saz A. K. Haemophilus influenzae type B resistant to ampicillin. A report of two cases. JAMA. 1974 Jul 15;229(3):298–301. [PubMed] [Google Scholar]
  6. May J. R., Davies J. Resistance of Haemophilus influenzae to trimethoprim. Br Med J. 1972 Aug 12;3(5823):376–377. doi: 10.1136/bmj.3.5823.376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Nelson J. D. Editorial: Should ampicillin be abandoned for treatment of Haemophilus influenzae disease? JAMA. 1974 Jul 15;229(3):322–324. [PubMed] [Google Scholar]
  8. Schiffer M. S., MacLowry J., Schneerson R., Robbins J. B., McReynolds J. W., Thomas W. J., Bailey D. W., Clarke E. J., Jr, Mueller E. J., Escamilla J. Clinical, bacteriological, and immunological characterisation of ampicillin-resistant Haemophilus influenzae type B. Lancet. 1974 Aug 3;2(7875):257–259. doi: 10.1016/s0140-6736(74)91416-0. [DOI] [PubMed] [Google Scholar]
  9. Thornsberry C., Kirven L. A. Antimicrobial susceptibility of Haemophilus influenzae. Antimicrob Agents Chemother. 1974 Nov;6(5):620–624. doi: 10.1128/aac.6.5.620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Tomeh M. O., Starr S. E., McGowan J. E., Jr, Terry P. M., Nahmias A. J. Ampicillin-resistant Haemophilus influenzae type B infection. JAMA. 1974 Jul 15;229(3):295–297. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES